
IO Biotech Inc
NASDAQ:IOBT

Fundamental Analysis


Revenue & Expenses Breakdown
IO Biotech Inc
Balance Sheet Decomposition
IO Biotech Inc
Current Assets | 42.3m |
Cash & Short-Term Investments | 37.1m |
Receivables | 922k |
Other Current Assets | 4.3m |
Non-Current Assets | 3.4m |
PP&E | 2.2m |
Other Non-Current Assets | 1.2m |
Free Cash Flow Analysis
IO Biotech Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
IO Biotech Inc
Revenue
|
0
USD
|
Operating Expenses
|
-97.6m
USD
|
Operating Income
|
-97.6m
USD
|
Other Expenses
|
-891k
USD
|
Net Income
|
-98.5m
USD
|
IOBT Profitability Score
Profitability Due Diligence
IO Biotech Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
IO Biotech Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
IOBT Solvency Score
Solvency Due Diligence
IO Biotech Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
IO Biotech Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IOBT Price Targets Summary
IO Biotech Inc
According to Wall Street analysts, the average 1-year price target for
IOBT
is 9.69 USD
with a low forecast of 6.06 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for IOBT is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?